Enkephalinase inhibitor
An enkephalinase inhibitor is a type of enzyme inhibitor which inhibits one or more members of the enkephalinase class of enzymes that break down the endogenous enkephalin opioid peptides. Examples include racecadotril, ubenimex (bestatin), RB-101, and D-phenylalanine, as well as the endogenous opioid peptides opiorphin and spinorphin.[1] It also includes RB-3007, Semax and Selank. Analgesic, anticraving, antidepressant, anxiolytic, and antidiarrheal effects are common properties of enkephalinase inhibitors.[1]
See also
- Enkephalinase
- Enkephalin
References
- Thanawala V, Kadam VJ, Ghosh R (October 2008). "Enkephalinase inhibitors: potential agents for the management of pain". Current Drug Targets. 9 (10): 887–94. doi:10.2174/138945008785909356. PMID 18855623. Archived from the original on 2012-03-18.
| Rehydration | |
|---|---|
| Intestinal anti-infectives | |
| Intestinal adsorbents |
|
| Antipropulsives (opioids) |
|
| Intestinal anti-inflammatory agents |
|
| Antidiarrheal micro-organisms | |
| Other antidiarrheals | |
| |
Opioid receptor modulators | |
|---|---|
| MOR |
|
| DOR |
|
| KOR |
|
| NOP |
|
| Unsorted |
|
| Others |
|
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.